Documented interactions with dopaminergic, serotonergic, GABAergic, and prostaglandin systems in animal models
Rucman)
Regulatory classification does not recognize BPC-157 as an approved drug or supplement, which means it is considered an investigational compound rather than a clinically established therapy
To date, there's only one published human study of BPC-157
Research shows the combination is effective for acute injuries (sprains, strains, tears), chronic conditions (tendinosis, arthritis, inflammatory disorders), post surgical recovery, inflammatory bowel conditions, joint health, and general tissue regeneration
BPC-157 frequently asked questions How do I reconstitute a 10 mg vial of BPC-157